The global CRO market size was valued at USD 42.6 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 6.5% from 2023 to 2031.
Global CRO Services Market: Breakup by Region, 2022 & 2031
Source: Primary Research and Secondary Research Analysis
The CRO (Contract Research Organization) services market is driven by several factors that include increasing demand for outsourcing clinical trials, the rising prevalence of chronic diseases, and the need to reduce drug development costs. Additionally, the growth of the pharmaceutical and biotechnology industries and the increasing trend towards personalized medicine are also driving the growth of the CRO services market.
One of the primary drivers of the CRO services market is the increasing demand for outsourcing clinical trials. Pharmaceutical and biotechnology companies are increasingly turning to CROs to conduct clinical trials due to their expertise, experience, and cost-effectiveness. Outsourcing clinical trials allows companies to focus on their core competencies while reducing drug development costs, which is critical in an increasingly competitive market.
The rising prevalence of chronic diseases is also driving the growth of the CRO services market. Chronic diseases such as cancer, diabetes, and cardiovascular diseases require extensive research and development to develop effective treatments. CROs offer a range of services such as clinical trial management, data management, and statistical analysis, which are essential for the development of treatments for chronic diseases.
Another driver of the CRO services market is the need to reduce drug development costs. Developing new drugs is a costly and time-consuming process that requires extensive research and development. CROs offer cost-effective solutions by providing expertise, experience, and resources to conduct clinical trials, manage data, and analyze results. By outsourcing these activities, pharmaceutical and biotechnology companies can reduce their development costs and speed up the drug development process.
The growth of the pharmaceutical and biotechnology industries is also driving the CRO services market. These industries are expanding rapidly, driven by increasing demand for new and innovative treatments, personalized medicine, and the rising prevalence of chronic diseases. As these industries grow, so does the demand for CRO services, which are essential for the development of new drugs and treatments.
Finally, the increasing trend towards personalized medicine is also driving the growth of the CRO services market. Personalized medicine requires extensive research and development to develop treatments that are tailored to individual patients. CROs offer a range of services such as biomarker discovery and validation, patient recruitment and retention, and pharmacogenomics that are essential for the development of personalized medicine.
In conclusion, the CRO services market is driven by several factors that include increasing demand for outsourcing clinical trials, the rising prevalence of chronic diseases, and the need to reduce drug development costs. Additionally, the growth of the pharmaceutical and biotechnology industries and the increasing trend towards personalized medicine are also driving the growth of the CRO services market. As the demand for new and innovative treatments continues to grow, so does the demand for CRO services, making it a lucrative and essential industry in the healthcare sector.
Market Segmentation:
Market Breakup By Service Type
Market Breakup By End User
Market Breakup By Application
Regional Analysis
Investments in facilities and resources in functional services such as central laboratories, imaging, and clinical supplies are predictable to drive the development of the contract research organisation (CROs) services marketplace in the province in the upcoming years and the country section of the report also provides separate marketplace impacting factors and changes in regulation in the marketplace locally that impacts the present and coming trends of the marketplace. Statistics points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Likewise, the occurrence and availability of international brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing estimate analysis of the nation data.
Market Breakup By Region
North America
Europe
Asia Pacific
Latin America
Middle East and Africa
Competitive Landscape
The contract research organization (CROs) services marketplace competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development (R&D) and the new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above information points providing are only related to the businesses' focus related to contract research organization (CROs) services marketplace.
Major players operating in the CRO Services Market are:
Iqvia
Laboratory Corporation of America Holdings
Novotech
Medpace Holdings, Inc.
Icon plc
KCR SA
PSI
Parexel International Corporation
Syneos Health
WuXi Biologics
Worldwide Clinical Trials
Ergomed plc
dMed Global
Hangzhou Tigermed Consulting Co., Ltd
Global CRO Services Market Research Report, 2020-2031
Table of Contents
Global CRO Services Market Research Report, 2020-2031
On Request
Our reports with in-depth insights will equip you to succeed in your business plans.
Get instant access to the information you need to make the right decision.
Explore where opportunities lie for you and mitigate the risks.
We are one of the most trusted brands setting benchmarks of excellence.